Cryptococcus gattii is one of the etiologic agents of cryptococcosis, a systemic mycosis that occurs in healthy and immunosuppressed humans and animals worldwide. Primary pulmonary infection caused by C. gattii is usually followed by fungal dissemination to the central nervous system, resulting in high mortality rates. In this context, animal models of cryptococcosis are useful in the study of fungal pathogenesis and host response against the pathogen, and for testing novel therapeutic options. The most frequently applied method to study fungal dissemination from the lungs to other organs is by culturing tissues, which is not accurate for the detection and quantification of fungal load at early stages of the infection. To overcome this problem, the purpose of this study was to develop a new method for the quantification of Cryptococcus dissemination. One C. gattii strain was efficiently radiolabeled with technetium-99m ( 99m Tc), without affecting viability of the cells. Further, the 99m Tc-C. gattii (111 MBq) strain was used to infect mice by intratracheal and intravenous route for biodistribution studies.
Introduction
Cryptococcus gattii is one of the etiologic agents of cryptococcosis, a neglected systemic mycosis that affects approximately 1 million people worldwide each year. It is the most common fungal infection of the central nervous system (CNS) in both healthy and immunocompromised individuals. Only 40% of these patients are alive after one year of active infection despite undergoing antifungal chemotherapy. 1, 2 Cryptococcal infections are acquired by inhalation of environmental spores or desiccated yeasts. 3, 4 During infection, the cells colonize the alveoli and further disseminate through the blood until they cross the blood-brain barrier (BBB), leading to cryptococcal meningoencephalitis, i.e. the most severe and lethal form of the disease. 5 Murine models have been useful in the study of cryptococcal infection, since, mice infected with Cryptococcus develop clinical symptoms similar to those observed in humans. [6] [7] [8] [9] In this context, studies focused on fungal dissemination to the CNS are important for better understanding of host-fungi interactions, including host defense mechanisms, fungal virulence, and studies on drug efficacy. The most frequently applied method to quantify fungal burden in mice tissues is based on plating and counting colonies on sabouraud dextrose agar (SDA). [9] [10] [11] Unfortunately, this method is not useful for the accurate detection and quantification of fungal load at early stages of the infection, probably because of problems associated with dilution in the plating technique. In a previous study, researchers labeled Escherichia coli with technetium-99m ( 99m Tc) to investigate bacterial translocation in an experimental model of obstructive jaundice. 12 In addition, ischemia followed by reperfusion of the small intestine as well as the role of arginine 13 and glutamine supplementation 14 in bacterial translocation using 99m Tc-E. coli were evaluated.
99m Tc is the most widely used radiotracer in nuclear medicine because of its availability and ideal physical characteristics. In daily medical practice, compounds radiolabeled with 99m Tc are used to obtain scintigraphic images of the thyroid gland, gastric mucosa, salivary glands and choroids plexus of the brain. 15 Normally the procedures employed in nuclear medicine allow early diagnosis of several diseases. Other radioactive isotopes have also been used for radiolabeling, among which indium-111 has been used in E. coli, Staphylococcus aureus, S. epidermidis, and Pseudomonas aeruginosa. 16, 17 However, there is a scarcity of studies focused on fungal labeling with radioactive isotopes. In light of these facts, the purpose of this study was to develop and evaluate a new method based on the radiolabeling of C. gattii with 99m Tc atoms to quantify fungal dissemination to the CNS at the early stages of infection in murine models.
Methods

Cryptococcus culture
Cryptococcus gattii strain L27/01 was used in this study. 
Fungal viability after radiolabeling
To investigate the impact of radiolabeling on the viability of C. gattii cells, viability of unlabeled C. gattii, C. gattii plus labeling reagents without 99m Tc, and 99m Tc-C. gattii was determined by plating yeast cells on SDA. The plates were incubated at 37
• C for 48 h, the colonies were counted, and the results were expressed as colony forming units per ml (cfu/ml).
Ethics statement for the animal protocols
The animal protocol was approved by the Comitê deÉtica no Uso de Animais (CEUA) from Universidade Federal de Minas Gerais (Protocol 34/2016) and all animal experiments were performed according to the guidelines of Brazilian Federal Law 11,794. All mice were housed in clean bedding (six mice per cage) with food and water ad libitum in a controlled environment with a 12 h light/dark cycle at 23
• C. For intratracheal (i.t.) and intravenous (i.v.) inoculation, mice were anesthetized by intraperitoneal (i.p.) injection of ketamine hydrochloride (80 mg/kg) and xylazine (15 mg/kg) in sterile saline. All efforts were made to minimize suffering. Mice were killed under anesthesia by cervical dislocation done by experienced animal handlers.
Intravenous and Intratracheal infection
C57BL/6 male mice (6 to 8 weeks old) were used in all experiments. Initially, the time-points to quantify the fungal burden in the brain of mice were determined. Groups of mice (n = 6) were infected by one route (i.v. or i.t.) with nonlabeled C. gattii (1 × 10 6 cfu) and killed 6, 24, 48, 72, or 96 h after inoculation for cfu determination in the brain and lungs. Further, a biodistribution assay was performed to test the dynamics of distribution of the 99m Tc-C. gattii complex in mice. Briefly, groups of mice (n = 6) were infected by i.v. route in the lateral caudal vein of the mice with 
Statistical analysis
All data were expressed as mean ± SEM (standard error of the mean). The results were evaluated using the MannWhitney test. Differences were considered significant at P < .05.
Results
Radiolabeling
As Stability of 99m Tc-C. gattii Table 3 shows that even 6 and 24 h after the radiolabeling procedure, the radiolabeled C. gattii were stable.
Viability
The in vitro viability study did not show significant differences between the investigated groups, revealing that both the reducing agent and the 99m Tc atoms had no effect on the fungal growth (Table 4) .
Biodistribution
As demonstrated in Table 5 , the biodistribution assay reveals rapid extravascular distribution, with smaller quantities in blood (around 0.1% ID/g) and high penetration in lungs (3-12% ID/g) in the first hour. Slightly lower levels of the 99m Tc-C. gattii complex were detected in brain, heart, After the radiolabeling process, yeast cells were plated on SDA to determine cfu per ml. The values represent the mean ± SD for each treatment (n = 3). and stomach, in which concentrations ranged from 0.1 to 3.0 %ID/g. These results were not altered after 6 h.
cfu and radioactivity dosage
The earliest time for cfu recovery from the brain was 24 h (Fig. 1) . Shorter durations (6 h postinfection) did not allow the recovery of colonies from the brain. Because of this result, the time duration of 6 h postinfection was chosen for subsequent experiments. The cfu in the lungs were easily quantified after 6 and 24 h of infection. The other Figure 2B and 2C reflect that the 99m Tc-C. gattii were detected in the brain 6 h postinoculation by radioactivity counting (%ID/g), in both intratracheal and intravenous murine models.
Discussion
Technetium-99m is an artificial element obtained by the radioactive decay of molybdenum (Mo). 99m Tc presents ideal nuclear properties such as physical half-life time (t 1/2 = 6.01 h), gamma emission, and energy (140 keV) suitable for in vivo studies. Thus, it is the most widely used radioisotope in nuclear medicine. 15, 19 Intratracheal inoculation with C. gattii provides an excellent model of human pulmonary cryptococcosis, mimicking natural infection. 8, 9, 11 Inoculation through the tail vein in mice has also been commonly used. Since i.v. inoculation bypasses the respiratory route, it is especially useful in elucidating determinants of pulmonary versus CNS infection. 23 The detection of fungal burden in the brain can be limited due to technical limitations, 24 and previous animal studies report conflicts between cfu and histology results. 25 Using the plating method, C. gattii was not detected in the brain homogenates of mice infected by i.t. routes within early hours of inoculation. Detection of C. gattii as determined by cfu was observed in the brain only 24 h postinfection. On the other hand, when the radioactivity counting was employed, the results showed radioactivity uptake by brain at 6 h for both infection routes, suggesting fungal dissemination and indicating that 99m Tc-C. gattii was able to cross the blood brain barrier. Even at 1 h, as assessed in the biodistribution assay, the complex was detected in the brain of mice infected by i.v. route. Although absolute uptake was lower in the brain, the %ID/g revealed that sufficient number of the yeast cells were available to cross the blood-brain barrier and establish fatal meningoencephalitis upon i.v. inoculation. 23 This enabled efficient labeling of Declaration of interest.
